2022
DOI: 10.3390/biomedicines10123243
|View full text |Cite
|
Sign up to set email alerts
|

High Risk, High Dose?—Pharmacotherapeutic Prescription Patterns of Offender and Non-Offender Patients with Schizophrenia Spectrum Disorder

Abstract: Compared to acute or community settings, forensic psychiatric settings, in general, have been reported to make greater use of antipsychotic polypharmacy and/or high dose pharmacotherapy, including overdosing. However, there is a scarcity of research specifically on offender patients with schizophrenia spectrum disorders (SSD), although they make up a large proportion of forensic psychiatric patients. Our study, therefore, aimed at evaluating prescription patterns in offender patients compared to non-offender p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
13
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(13 citation statements)
references
References 55 publications
0
13
0
Order By: Relevance
“…They were more likely to have a prescription for antidepressants during the referenced hospitalisation. This observation is not only found when comparing merely the patients with a suicidal history: a higher rate of antidepressant pharmacotherapy in NOP with SSD than OP with SSD has been observed in general [33]. While an adjunctive antidepressant can be beneficial to patients with SSD, especially regarding negative symptoms, it seems to be a less common prescription in OP, possibly due to fear of re-exacerbation of positive psychotic symptoms and an increased risk of side effects [34,35].…”
Section: Discussionmentioning
confidence: 92%
“…They were more likely to have a prescription for antidepressants during the referenced hospitalisation. This observation is not only found when comparing merely the patients with a suicidal history: a higher rate of antidepressant pharmacotherapy in NOP with SSD than OP with SSD has been observed in general [33]. While an adjunctive antidepressant can be beneficial to patients with SSD, especially regarding negative symptoms, it seems to be a less common prescription in OP, possibly due to fear of re-exacerbation of positive psychotic symptoms and an increased risk of side effects [34,35].…”
Section: Discussionmentioning
confidence: 92%
“…Among these studies, four employed ML models to predict VB during the current admission ( 35 , 41 , 47 , 51 ). Additionally, nine studies categorized patients based on the occurrence of VB prior to their current admission ( 38 40 , 43 , 44 , 46 , 48 50 ), while another four classified patients into violent and non-violent groups by retrospectively reviewing their medical records since their disease onset ( 36 , 37 , 42 , 45 ). Moreover, eight studies were part of a larger project investigating the relationship between SSD and offending and used the same dataset of offender patients as their sample population ( 39 , 41 , 42 , 45 , 46 , 48 50 ).…”
Section: Resultsmentioning
confidence: 99%
“…(2022, 2023) in two separate studies evaluated the differences between offender and non-offender SSD patients regarding psychiatric pr e scription patterns and illness-related factors ( 46 , 49 ). Also, ten studies analyzed the relationship between different rating tools scores and VB in patients with SSD ( 36 , 38 , 39 , 41 , 43 , 45 , 46 , 48 50 ), including the Brief Psychiatric Rating Scale (BPRS) ( 38 , 43 , 52 ), the Psychopathy Checklist: Screening Version (PCL-SV), the Historical, Clinical and Risk management (HCR-20) scale ( 38 , 53 ), The Barratt Impulsiveness Scale version 11 (BIS-11) ( 38 , 54 ), the Positive And Negative Symptom Scale (PANSS) ( 36 , 39 , 41 , 43 , 45 , 46 , 48 50 , 55 ), the Social Disability Screening Schedule (SDSS) ( 43 ), Insight and Treatment Attitude Questionnaire (ITAQ) ( 47 , 56 ), Family Adaptation, Partnership, Growth, Affection and Resolve (APGAR) ( 47 , 57 ), Social Support Rating Scale (SSRS) ( 47 , 58 ), and Family Burden Scale of Disease (FBS) ( 47 , 59 ). Furthermore, two studies evaluated neuroimaging data of patients as VB predictors, along with sociodemographic features.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations